steroid 5-alpha reductase
Genetic and pharmacological evidence for more than one human steroid 5 alpha reductase
9
Molecular genetics of steroid 5 alpha reductase 2 deficiency
12
Tissue distribution and ontogeny of steroid 5 alpha reductase isozyme expression
9
Review Article Association between steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and prostate cancer risk: a meta-analysis study
13
Oxidative stress in prostate hyperplasia and carcinogenesis
19
A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits
5
Induction of a deficiency of steroid delta 4 5 alpha reductase activity in liver by a porphyrinogenic drug
7
The role of 5 alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
6
Role of 5 alpha-reductase inhibitors in the management of prostate cancer
8
Underlying Genetic Defects in Diseases of Sexual Development in the Island of Cyprus Support the Founder Effect
14
Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei
16
Pre Androgen Ablation Prostate Cancer Patients Who Bleed Do Well with 5 Alpha Reductase Inhibitors
9
High dose androgen therapy in male pseudohermaphroditism due to 5 alpha reductase deficiency and disorders of the androgen receptor
14
Impact of 5-Alpha Reductase Inhibitors Treatment for Benign Prostatic Hyperplasia on Erectile Dysfunction: A Meta-Analysis
6
Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
12
Alpha-substituted cystines as substrates for cystine reductase, and L-amino acid oxidase.
69
Pyrroline 5 carboxylate reductase in human erythrocytes
6
A population-based study of polymorphisms in genes related to sex hormones and abdominal aortic aneurysm
13
<p>Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide</p>
14
Effect of prostatic inflammation on the outcome of patients with benign prostatic hyperplasia treated by transurethral resection of the prostate
48